Zaeske Adam H.
SEC CIK 2064712 · EDGAR
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| HRMY | Harmony Biosciences Holdings, Inc. | Chief COMMERCIAL Off | 7,500 | — | — | 2 | 2026-04-07 | 2026-04-07 |
Most active insiders at HRMY, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Budur Kumar | Chief MEDICAL Off | — | $3.11M |
| 2 | Kapadia Sandip | CFO | — | $1.80M |
| 3 | Dayno Jeffrey M. | Pres, CEO, Dir | — | $1.04M |
| 4 | Zaeske Adam H. | Chief COMMERCIAL Off | — | — |
| 5 | Serafin Andrew | Chief STRATEGY Off | — | — |
Transactions 2
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-04-09 16:15 | 2026-04-07 | HRMY | Harmony Biosciences Holdings, Inc. | Zaeske Adam H. | Chief COMMERCIAL Off | M - OptEx | $0.00 | +7,500 | 7,500 | New | $0 |
| D | 2026-04-09 16:15 | 2026-04-07 | HRMY | Harmony Biosciences Holdings, Inc. | Zaeske Adam H. | Chief COMMERCIAL Off | F - Tax | $27.62 | -3,173 | 4,327 | -42% | -$87.6K |
Purchase Sale Sale after option exercise All abbreviations